Medicover Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

John Stubbington

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	0.5%
Yönetim ortalama görev süresi	less than a year
Yönetim Kurulu ortalama görev süresi	10.3yrs

Son yönetim güncellemeleri

Recent updates

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

May 09

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Apr 28

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Apr 14

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Mar 21

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Feb 09 Strong cash generation supports debt reduction and further investments, boosting future earnings growth positively.

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Dec 12

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Nov 07

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Oct 24

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16

CEO

John Stubbington (56 yo)

no data

Görev süresi

Mr. John Stubbington serves as Member of the Supervisory Board of Dom Lekarski S.A. since 2021. Mr. Stubbington served as Chief Operating Officer of Healthcare Services of Medicover AB (publ) until May 01,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Fredrik Rågmark	Executive Officer	no data	€3.31m	1.12% SEK 409.0m
John Stubbington	Chief Executive Officer	no data	Veri yok	0.53% SEK 192.7m
Anand Patel	Chief Financial Officer	less than a year	Veri yok	0.0021% SEK 750.6k
Jaroslaw Urbanczyk	Chief Information Officer	5.6yrs	Veri yok	0.010% SEK 3.8m
Hanna Bjellquist	Head of Investor Relations	no data	Veri yok	Veri yok
Jenny Brandt	General Legal Counsel	no data	Veri yok	0.040% SEK 14.6m
Andrew Vallance-Owen	Chief Marketing Officer	no data	Veri yok	Veri yok
Kamila Skorupinski	Chief People Officer	1.1yrs	Veri yok	Veri yok
Staffan Ternstrom	Chief Operating Officer for Diagnostic Services	3.9yrs	Veri yok	0.099% SEK 36.3m

0.8yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: MCOV B 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 0.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Robert Jochnick	Honorary Board Member	no data	Veri yok	1.2% SEK 440.0m
Fredrik Stenmo	Independent Chairman	20.3yrs	€131.10k	4.38% SEK 1.6b
Margareta Nordenvall	Independent Director	24.3yrs	€68.90k	0.060% SEK 21.8m
Arno Bohn	Independent Director	24.3yrs	€65.80k	0.20% SEK 72.7m
Cecil Michael Flemming	Independent Director	10.3yrs	€81.50k	Veri yok
Anne Berner	Independent Director	3.1yrs	€62.80k	Veri yok
Azita Shariati	Independent Director	3.1yrs	€65.80k	0.0015% SEK 534.5k
Peder Jochnick	Independent Director	13.3yrs	€56.80k	2.57% SEK 942.0m
Sonali Chandmal	Independent Director	8.3yrs	€78.90k	0.017% SEK 6.1m
Claudia Olsson	Director	less than a year	Veri yok	Veri yok

10.3yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: MCOV B 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.3 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/05/19 01:30
Gün Sonu Hisse Fiyatı	2025/05/19 00:00
Kazançlar	2025/03/31
Yıllık Kazançlar	2024/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Medicover AB (publ) 9 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
null null	ABG Sundal Collier
null null	ABG Sundal Collier Sponsored
Kristofer Liljeberg-Svensson	Carnegie Investment Bank AB

Medicover Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

Honorary Board Member recently sold kr1.2m worth of stock

Insufficient new directors

Medicover AB (Publ) Approves Board Elections

Medicover AB (Publ) Announces CEO Changes, Effective 1 May 2025

Insider recently bought kr498k worth of stock

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Recent updates

Honorary Board Member recently sold kr1.2m worth of stock

Medicover's (STO:MCOV B) Earnings May Just Be The Starting Point

Consensus EPS estimates increase by 10%

Insufficient new directors

Medicover AB (Publ) Approves Board Elections

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 41% Above Its Share Price

Upcoming dividend of €0.15 per share

Investors Interested In Medicover AB (publ)'s (STO:MCOV B) Revenues

Medicover AB (publ) (OM:MCOV B) acquired Cityfit Sp Z O O in a transaction valued at approximately PLN 570 million.

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Medicover AB (publ) Proposes Dividend for 2024, Payable on 9 May 2025

Medicover (STO:MCOV B) Might Be Having Difficulty Using Its Capital Effectively

Dividend of €0.15 announced

Medicover AB (Publ) Proposes Dividend for 2024

Medicover AB (Publ) Announces CEO Changes, Effective 1 May 2025

New Investments In India's And Romania's Healthcare Services Will Expand Future Global Reach

Medicover AB (publ)'s (STO:MCOV B) Popularity With Investors Is Clear

Consensus EPS estimates fall by 65%

Insider recently bought kr498k worth of stock

The Strong Earnings Posted By Medicover (STO:MCOV B) Are A Good Indication Of The Strength Of The Business

Third quarter 2024 earnings released: €0.029 loss per share (vs €0.007 loss in 3Q 2023)

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Here's What To Make Of Medicover's (STO:MCOV B) Decelerating Rates Of Return

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Second quarter 2024 earnings released: EPS: €0.042 (vs €0.037 in 2Q 2023)

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

General Legal Counsel recently sold kr1.2m worth of stock

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023)

Upcoming dividend of €0.12 per share

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

New minor risk - Earnings quality

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Dividend of €0.12 announced

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Full year 2023 earnings: EPS exceeds analyst expectations

Now 24% undervalued

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Consensus EPS estimates increase by 27%

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Independent Chairman recently bought kr3.9m worth of stock

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

New minor risk - Earnings quality

Third quarter 2023 earnings released

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Independent Director recently bought kr303k worth of stock

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Independent Director recently bought kr1.4m worth of stock

Independent Chairman recently bought kr6.3m worth of stock

Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022)

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Chief Information Officer recently bought kr321k worth of stock

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

Consensus EPS estimates fall by 10%

Now 21% undervalued after recent price drop

Upcoming dividend of €0.12 per share at 0.7% yield

Full year 2022 earnings: Revenues in line with analyst expectations